These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22183132)

  • 21. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
    Murata S; Izumi T; Ito H
    Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations.
    Smyth H; Hickey AJ; Brace G; Barbour T; Gallion J; Grove J
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1033-41. PubMed ID: 17012116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing standardised methods for comparing aqueous droplet inhalers.
    Berg E; Svensson JO
    Pharmeur Sci Notes; 2006 Dec; 2006(2):9-15. PubMed ID: 17691209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles of metered-dose inhaler design.
    Newman SP
    Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporally and Spatially Resolved x-ray Fluorescence Measurements of in-situ Drug Concentration in Metered-Dose Inhaler Sprays.
    Duke DJ; Kastengren AL; Mason-Smith N; Chen Y; Young PM; Traini D; Lewis D; Edgington-Mitchell D; Honnery D
    Pharm Res; 2016 Apr; 33(4):816-25. PubMed ID: 26563204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Heimbecher S; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
    Zhu B; Haghi M; Goud M; Young PM; Traini D
    Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of two methods to determine the solubility of compounds in aerosol propellants.
    Gupta A; Myrdal PB
    Int J Pharm; 2005 Mar; 292(1-2):201-9. PubMed ID: 15725567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug distribution transients in solution and suspension-based pressurised metered dose inhaler sprays.
    Duke DJ; Scott HN; Kusangaya AJ; Kastengren AL; Matusik K; Young P; Lewis D; Honnery D
    Int J Pharm; 2019 Jul; 566():463-475. PubMed ID: 31173800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metered-dose inhaler efficiency enhancement: a case study and novel design.
    Fadl A; Wang J; Zhang Z
    Inhal Toxicol; 2010 Jun; 22(7):601-9. PubMed ID: 20387999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
    Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
    AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.
    Martin AR; Kwok DY; Finlay WH
    J Aerosol Med; 2005; 18(2):218-24. PubMed ID: 15966776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.